Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06402786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

First-in-human Trial of Home Brain Pressure Measured Using Kitea ICP Sensor, Placed During Hydrocephalus Shunt Surgery.

Study acronym: HomeICP
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 13, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Jun 2025 to Apr 2026v3 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 20 to confirmed 21
    • Study completion date: Dec 2025 to Apr 2026
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2024 to May 27, 2024
    • Site details revised
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with hydrocephalus have an abnormal build-up of fluid around the brain and need a tube surgically implanted to drain that fluid. Patients and their caregivers live with the constant fear that the tube will block. Warning symptoms include irritability, headaches and vomiting. Unfortunately, there is no way of telling when fluid build-up is causing a rise in brain pressure and potentially impeding blood flow to the brain (life threatening) except for a brain scan in hospital and possibly hospitalisation. The investigators want to improve the lives of patients with hydrocephalus. They have developed a tool for parents and caregivers to monitor the pressure in the brain remotely via a sensor placed alongside the drainage tube. The device has been shown to be safe and to give reliable brain pressure readings using a large animal model (sheep). This study is a first-in-human safety study to show it is safe for patient use.
Trial Details
NCT Number NCT06402786
Lead Sponsor University of Auckland, New Zealand
Collaborators: Health Research Council, New Zealand, Auckland City Hospital, Kitea Health Ltd
Conditions
(from sponsor)
Hydrocephalus
Related terms Hydrocephalus
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov